Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-21-000413
Filing Date
2021-07-08
Accepted
2021-07-08 13:30:40
Documents
2
Group Members
GIL AHARONROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G cellectar_13g.htm SC 13G 123373
2 EXHIBIT A ex_a.htm EX-99.A 7264
  Complete submission text file 0001019056-21-000413.txt   132452
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85798 | Film No.: 211079775
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8
Business Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: SC 13G